Evidence map›Paper›PMID 27825668›Full record

ReviewTrends in molecular medicine2016

Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.

Briana R Wilson, Alexander R Bogdan, Masaki Miyazawa, Kazunori Hashimoto, Yoshiaki Tsuji

Open access · bronzeAbstract readReview
In one paragraph

Review in Trends in molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 209 papers.

0numbers the graph read from it
0cells of the map it votes in
209citing papers in PubMed
20.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

209 citing papers in PubMed, 471 citations in OpenAlex.

  1. Trial
  2. Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Proteomic Analysis of Influenza.Advances in experimental medicine and biology · 2026
    Review
  10. Article
  11. Innovative Nanocarriers: Magnetosomes in the Fight against Cancer.Anti-cancer agents in medicinal chemistry · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Halogenated quinoline kill agent rapidly induces iron starvation ofMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2025
    Article
  18. Article
  19. Article
  20. Review

149 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Briana R WilsonDepartment of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7633, USA.
Alexander R BogdanDepartment of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7633, USA.
Masaki MiyazawaDepartment of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7633, USA.
Kazunori HashimotoDepartment of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7633, USA.
Yoshiaki TsujiDepartment of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7633, USA. Electronic address: ytsuji@ncsu.edu.
North Carolina State University · US

Funding

TRAINING IN BIOCHEMICAL AND ENVIRONMENTAL TOXICOLOGYT32ES007046 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Seth William Kullman · 1985 to 2026
$5.1M
Regulation and Role of CREB in Cellular Genotoxic Response to XenobioticsR01GM095550 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI TSUJI, YOSHIAKI · 2011 to 2015
$1.2M
Regulation of Antioxidant Genes and Oxidative StressR01GM088392 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI TSUJI, YOSHIAKI · 2011 to 2014
$1.1M
NIEHS NIH HHS T32 ES007046NIGMS NIH HHS R01 GM088392NIGMS NIH HHS R01 GM095550
6 · The paper itself

Abstract

Iron is an essential nutrient for life. During infection, a fierce battle of iron acquisition occurs between the host and bacterial pathogens. Bacteria acquire iron by secreting siderophores, small ferric iron-binding molecules. In response, host immune cells secrete lipocalin 2 (also known as siderocalin), a siderophore-binding protein, to prevent bacterial reuptake of iron-loaded siderophores. To counter this threat, some bacteria can produce lipocalin 2-resistant siderophores. This review discusses the recently described molecular mechanisms of siderophore iron trafficking between host and bacteria, highlighting the therapeutic potential of exploiting pathogen siderophore machinery for the treatment of antibiotic-resistant bacterial infections. Because the latter reflect a persistent problem in hospital settings, siderophore-targeting or siderophore-based compounds represent a promising avenue to combat such infections.

Indexed as

Host-Pathogen InteractionsAnimalsAnti-Bacterial AgentsBacteriaBacterial InfectionsDrug DiscoveryHumansIronLipocalin-2SiderophoresAnti-Bacterial AgentsIronLipocalin-2SiderophoreshypoxiaironLcn2mitophagysiderocalinsiderophore

Identifiers

PMID27825668
PMCPMC5135587
OpenAlexW2548630962

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.